Unexpected new roles for heparanase in Type 1 diabetes and immune gene regulation

Matrix Biol. 2013 Jun 24;32(5):228-33. doi: 10.1016/j.matbio.2013.02.007. Epub 2013 Mar 13.

Abstract

Heparanase (Hpse) is an endo-β-d-glucuronidase that degrades the glycosaminoglycan heparan sulfate (HS) in basement membranes (BMs) to facilitate leukocyte migration into tissues. Heparanase activity also releases HS-bound growth factors from the extracellular matrix (ECM), a function that aids wound healing and angiogenesis. In disease states, the degradation of HS in BMs by heparanase is well recognized as an invasive property of metastatic cancer cells. Recent studies by our group, however, have identified unexpected new roles for heparanase and HS. First, we discovered that in Type 1 diabetes (T1D) (i) HS in the pancreatic islet BM acts as a barrier to invading cells and (ii) high levels of HS within the insulin-producing islet beta cells themselves are critical for beta cell survival, protecting the cells from free radical-mediated damage. Furthermore, catalytically active heparanase produced by autoreactive T cells and other insulitis mononuclear cells was shown to degrade intra-islet HS, increasing the susceptibility of islet beta cells to free radical damage and death. This totally novel molecular explanation for the onset of T1D diabetes opens up new therapeutic approaches for preventing disease progression. Indeed, administration of the heparanase inhibitor, PI-88, dramatically reduced T1D incidence in diabetes-prone NOD mice, preserved islet beta cell HS and reduced islet inflammation. Second, in parallel studies it has been shown that heparanase and HS can be transported to the nucleus of cells where they impact directly or indirectly on gene transcription. Based on ChIP-on-chip studies heparanase was found to interact with the promoters and transcribed regions of several hundred genes and micro-RNAs in activated Jurkat T cells and up-regulate transcription, with many of the target genes/micro-RNAs being involved in T cell differentiation. At the molecular level, nuclear heparanase appears to regulate histone 3 lysine 4 (H3K4) methylation by influencing the recruitment of demethylases to transcriptionally active genes. These studies have unveiled new functions for heparanase produced by T lymphocytes, with the enzyme mediating unexpected intracellular effects on T cell differentiation and insulin-producing beta cell survival in T cell-dependent autoimmune T1D.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Cell Proliferation
  • Diabetes Mellitus, Type 1 / drug therapy
  • Diabetes Mellitus, Type 1 / enzymology*
  • Diabetes Mellitus, Type 1 / immunology
  • Diabetes Mellitus, Type 1 / pathology
  • Enzyme Inhibitors / pharmacology
  • Extracellular Matrix / chemistry
  • Extracellular Matrix / immunology
  • Extracellular Matrix / metabolism
  • Free Radicals / antagonists & inhibitors
  • Free Radicals / metabolism
  • Gene Expression Regulation / immunology
  • Glucuronidase / genetics
  • Glucuronidase / metabolism*
  • Heparitin Sulfate / biosynthesis*
  • Heparitin Sulfate / immunology
  • Humans
  • Islets of Langerhans / drug effects
  • Islets of Langerhans / enzymology*
  • Islets of Langerhans / immunology
  • Islets of Langerhans / pathology
  • Mice
  • Oligosaccharides / pharmacology
  • Signal Transduction
  • T-Lymphocytes / drug effects
  • T-Lymphocytes / immunology
  • T-Lymphocytes / pathology

Substances

  • Enzyme Inhibitors
  • Free Radicals
  • Oligosaccharides
  • phosphomannopentaose sulfate
  • Heparitin Sulfate
  • heparanase
  • Glucuronidase